Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 82


Use of Granulocyte-colony Stimulating Factor During Chemotherapy and Its Association With CA27.29 and Circulating Tumor Cells-Results From the SUCCESS A Trial.

Hepp P, Fasching PA, Beckmann MW, Fehm T, Salmen J, Hagenbeck C, Jäger B, Widschwendter P, de Gregorio N, Schochter F, Mahner S, Harbeck N, Weissenbacher T, Kurt AG, Friedl TWP, Janni W, Rack B.

Clin Breast Cancer. 2018 Jun 18. pii: S1526-8209(17)30674-2. doi: 10.1016/j.clbc.2018.06.006. [Epub ahead of print]


Prevalence of circulating tumor cells in early breast cancer patients 2 and 5 years after adjuvant treatment.

Bauer ECA, Schochter F, Widschwendter P, DeGregorio A, Andergassen U, Friedl TWP, Fasching PA, Fehm T, Schneeweiss A, Beckmann MW, Pantel K, Janni W, Rack B, Scholz C; SUCCESS Study Group.

Breast Cancer Res Treat. 2018 Jun 21. doi: 10.1007/s10549-018-4856-1. [Epub ahead of print]


New Taxa of Streptophyte Algae (Streptophyta) from Terrestrial Habitats Revealed Using an Integrative Approach.

Mikhailyuk T, Lukešová A, Glaser K, Holzinger A, Obwegeser S, Nyporko S, Friedl T, Karsten U.

Protist. 2018 Jul;169(3):406-431. doi: 10.1016/j.protis.2018.03.002. Epub 2018 Mar 20.


Association of Circulating Tumor Cell Status With Benefit of Radiotherapy and Survival in Early-Stage Breast Cancer.

Goodman CR, Seagle BL, Friedl TWP, Rack B, Lato K, Fink V, Cristofanilli M, Donnelly ED, Janni W, Shahabi S, Strauss JB.

JAMA Oncol. 2018 May 3:e180163. doi: 10.1001/jamaoncol.2018.0163. [Epub ahead of print]


Influence of Prognostic Factors on Lymph Node Involvement in Endometrial Cancer: A Single-Center Experience.

Widschwendter P, Bauer E, De Gregorio N, Bekes I, Janni W, Scholz C, Friedl TWP.

Int J Gynecol Cancer. 2018 Jul;28(6):1145-1152. doi: 10.1097/IGC.0000000000001290.


Prognostic Impact of Weight Change During Adjuvant Chemotherapy in Patients With High-Risk Early Breast Cancer: Results From the ADEBAR Study.

Mutschler NS, Scholz C, Friedl TWP, Zwingers T, Fasching PA, Beckmann MW, Fehm T, Mohrmann S, Salmen J, Ziegler C, Jäger B, Widschwendter P, de Gregorio N, Schochter F, Mahner S, Harbeck N, Weissenbacher T, Jückstock J, Janni W, Rack B.

Clin Breast Cancer. 2018 Apr;18(2):175-183. doi: 10.1016/j.clbc.2018.01.008. Epub 2018 Jan 31.


Prenatally Diagnosed Single Umbilical Artery (SUA) - Retrospective Analysis of 1169 Fetuses.

Friebe-Hoffmann U, Hiltmann A, Friedl TWP, Lato K, Hammer R, Janni W, Kozlowski P.

Ultraschall Med. 2018 Mar 28. doi: 10.1055/s-0043-123463. [Epub ahead of print]


Endocrine Treatment with 2 Years of Tamoxifen versus 2 Years of Exemestane in Postmenopausal Patients with High-Risk Early Breast Cancer and Persisting Circulating Tumor Cells - First Results of the SUCCESS C Endocrine Treatment Sub-Study.

Schochter F, Rack B, Tzschaschel M, Polasik A, Andergassen U, Trapp E, Alunni-Fabbroni M, Schneeweiss A, Müller V, Pantel K, Gade J, Lorenz R, Rezai M, Tesch H, Soeling U, Fehm T, Mahner S, Schindlbeck C, Lichtenegger W, Beckmann MW, Fasching PA, Janni W, Friedl TWP; SUCCESS Study Group.

Oncol Res Treat. 2018;41(3):93-98. doi: 10.1159/000485566. Epub 2018 Feb 27.


Whole blood microRNAs as potential biomarkers in post-operative early breast cancer patients.

Alunni-Fabbroni M, Majunke L, Trapp EK, Tzschaschel M, Mahner S, Fasching PA, Fehm T, Schneeweiss A, Beck T, Lorenz R, Friedl TWP, Janni W, Rack B; SUCCESS Study Group.

BMC Cancer. 2018 Feb 6;18(1):141. doi: 10.1186/s12885-018-4020-7.


Hypotension due to spinal anesthesia influences fetal circulation in primary caesarean sections.

Lato K, Bekes I, Widschwendter P, Friedl TWP, Janni W, Reister F, Froeba G, Friebe-Hoffmann U.

Arch Gynecol Obstet. 2018 Mar;297(3):667-674. doi: 10.1007/s00404-017-4641-0. Epub 2018 Jan 12.


Circulating Tumour Cells, Circulating Tumour DNA and Circulating MicroRNA in Metastatic Breast Carcinoma - What is the Role of Liquid Biopsy in Breast Cancer?

Polasik A, Tzschaschel M, Schochter F, de Gregorio A, Friedl TWP, Rack B, Hartkopf A, Fasching PA, Schneeweiss A, Müller V, Huober J, Janni W, Fehm T.

Geburtshilfe Frauenheilkd. 2017 Dec;77(12):1291-1298. doi: 10.1055/s-0043-122884. Epub 2017 Dec 18.


Increased single-strand annealing rather than non-homologous end-joining predicts hereditary ovarian carcinoma.

Deniz M, Romashova T, Kostezka S, Faul A, Gundelach T, Moreno-Villanueva M, Janni W, Friedl TWP, Wiesmüller L.

Oncotarget. 2017 Oct 9;8(58):98660-98676. doi: 10.18632/oncotarget.21720. eCollection 2017 Nov 17.


Comparison of Fetomaternal Outcome between 47 Deliveries Following Successful External Cephalic Version for Breech Presentation and 7456 Deliveries Following Spontaneous Cephalic Presentation.

de Gregorio N, Friedl T, Schramm A, Reister F, Janni W, Ebner F.

Gynecol Obstet Invest. 2017 Aug 25. doi: 10.1159/000480013. [Epub ahead of print]


LKB1 pro-oncogenic activity triggers cell survival in circulating tumor cells.

Trapp EK, Majunke L, Zill B, Sommer H, Andergassen U, Koch J, Harbeck N, Mahner S, Friedl TWP, Janni W, Rack B, Alunni-Fabbroni M.

Mol Oncol. 2017 Nov;11(11):1508-1526. doi: 10.1002/1878-0261.12111. Epub 2017 Sep 30.


Value of endometrial thickness assessed by transvaginal ultrasound for the prediction of endometrial cancer in patients with postmenopausal bleeding.

Schramm A, Ebner F, Bauer E, Janni W, Friebe-Hoffmann U, Pellegrino M, De Gregorio N, Friedl TWP.

Arch Gynecol Obstet. 2017 Aug;296(2):319-326. doi: 10.1007/s00404-017-4439-0. Epub 2017 Jun 20.


The HER2 phenotype of circulating tumor cells in HER2-positive early breast cancer: A translational research project of a prospective randomized phase III trial.

Jaeger BAS, Neugebauer J, Andergassen U, Melcher C, Schochter F, Mouarrawy D, Ziemendorff G, Clemens M, V Abel E, Heinrich G, Schueller K, Schneeweiss A, Fasching P, Beckmann MW, Scholz C, Friedl TWP, Friese K, Pantel K, Fehm T, Janni W, Rack B.

PLoS One. 2017 Jun 6;12(6):e0173593. doi: 10.1371/journal.pone.0173593. eCollection 2017.


Prevalence of Circulating Tumor Cells After Adjuvant Chemotherapy With or Without Anthracyclines in Patients With HER2-negative, Hormone Receptor-positive Early Breast Cancer.

Schramm A, Schochter F, Friedl TWP, de Gregorio N, Andergassen U, Alunni-Fabbroni M, Trapp E, Jaeger B, Heinrich G, Camara O, Decker T, Ober A, Mahner S, Fehm TN, Pantel K, Fasching PA, Schneeweiss A, Janni W, Rack BK; SUCCESS Study Group.

Clin Breast Cancer. 2017 Jul;17(4):279-285. doi: 10.1016/j.clbc.2016.11.008. Epub 2017 Jan 10.


Association of CA27.29 and Circulating Tumor Cells Before and at Different Times After Adjuvant Chemotherapy in Patients with Early-stage Breast Cancer - The SUCCESS Trial.

Hepp P, Andergassen U, Jäger B, Trapp E, Alunni-Fabbroni M, Friedl TW, Hecker N, Lorenz R, Fasching P, Schneeweiss A, Fehm T, Janni W, Rack B.

Anticancer Res. 2016 Sep;36(9):4771-6.


Education in Disaster Management: What Do We Offer and What Do We Need? Proposing a New Global Program.

Khorram-Manesh A, Lupesco O, Friedl T, Arnim G, Kaptan K, Djalali AR, Foletti M, Ingrasia PL, Ashkenazi M, Arculeo C, Fischer P, Hreckovski B, Komadina R, Voigt S, Carlström E, James J; DITAC (Disaster Training Curriculum) partners.

Disaster Med Public Health Prep. 2016 Dec;10(6):854-873. doi: 10.1017/dmp.2016.88. Epub 2016 Jul 20.


Detection of circulating tumor cells using manually performed immunocytochemistry (MICC) does not correlate with outcome in patients with early breast cancer - Results of the German SUCCESS-A- trial.

Jueckstock J, Rack B, Friedl TW, Scholz C, Steidl J, Trapp E, Tesch H, Forstbauer H, Lorenz R, Rezai M, Häberle L, Alunni-Fabbroni M, Schneeweiss A, Beckmann MW, Lichtenegger W, Fasching PA, Pantel K, Janni W; SUCCESS Study Group.

BMC Cancer. 2016 Jul 7;16:401. doi: 10.1186/s12885-016-2454-3.


Biodiversity of green algae covering artificial hard substrate surfaces in a suburban environment: a case study using molecular approaches.

Hallmann C, Hoppert M, Mudimu O, Friedl T.

J Phycol. 2016 Oct;52(5):732-744. doi: 10.1111/jpy.12437. Epub 2016 Aug 24.


Widespread green algae Chlorella and Stichococcus exhibit polar-temperate and tropical-temperate biogeography.

Hodač L, Hallmann C, Spitzer K, Elster J, Faßhauer F, Brinkmann N, Lepka D, Diwan V, Friedl T.

FEMS Microbiol Ecol. 2016 Aug;92(8). pii: fiw122. doi: 10.1093/femsec/fiw122. Epub 2016 Jun 7.


Determination of Interleukin-4, -5, -6, -8 and -13 in Serum of Patients with Breast Cancer Before Treatment and its Correlation to Circulating Tumor Cells.

König A, Vilsmaier T, Rack B, Friese K, Janni W, Jeschke U, Andergassen U, Trapp E, Jückstock J, Jäger B, Alunni-Fabbroni M, Friedl T, Weissenbacher T; SUCCESS STUDY GROUP.

Anticancer Res. 2016 Jun;36(6):3123-30.


Comparison of seroma production in breast conserving surgery with or without intraoperative radiotherapy as tumour bed boost.

Ebner F, Schramm A, Bottke D, Friedl TW, Wiegel T, Fink V, Lato K, Bekes I, Janni W, de Gregorio N.

Arch Gynecol Obstet. 2016 Oct;294(4):861-6. doi: 10.1007/s00404-016-4124-8. Epub 2016 Jun 2.


Toxicity Assessment of a Phase III Study Evaluating FEC-Doc and FEC-Doc Combined with Gemcitabine as an Adjuvant Treatment for High-Risk Early Breast Cancer: the SUCCESS-A Trial.

Schröder L, Rack B, Sommer H, Koch JG, Weissenbacher T, Janni W, Schneeweiss A, Rezai M, Lorenz R, Jäger B, Schramm A, Häberle L, Fasching PA, Friedl TW, Beckmann MW, Scholz C.

Geburtshilfe Frauenheilkd. 2016 May;76(5):542-550.


Taxonomic revision and species delimitation of coccoid green algae currently assigned to the genus Dictyochloropsis (Trebouxiophyceae, Chlorophyta).

Škaloud P, Friedl T, Hallmann C, Beck A, Dal Grande F.

J Phycol. 2016 Aug;52(4):599-617. doi: 10.1111/jpy.12422. Epub 2016 Jun 15.


Short term quality of life with epirubicin-fluorouracil-cyclophosphamid (FEC) and sequential epirubicin/cyclophosphamid-docetaxel (EC-DOC) chemotherapy in patients with primary breast cancer - Results from the prospective multi-center randomized ADEBAR trial.

Schwentner L, Harbeck N, Singer S, Eichler M, Rack B, Forstbauer H, Wischnik A, Scholz C, Huober J, Friedl TW, Weissenbacher T, Härtl K, Kiechle M, Janni W, Fink V.

Breast. 2016 Jun;27:69-77. doi: 10.1016/j.breast.2016.03.003. Epub 2016 Apr 4.


Randomised phase III trial of FEC120 vs EC-docetaxel in patients with high-risk node-positive primary breast cancer: final survival analysis of the ADEBAR study.

Janni W, Harbeck N, Rack B, Augustin D, Jueckstock J, Wischnik A, Annecke K, Scholz C, Huober J, Zwingers T, Friedl TW, Kiechle M.

Br J Cancer. 2016 Apr 12;114(8):863-71. doi: 10.1038/bjc.2016.82. Epub 2016 Mar 31.


Pooled Analysis of the Prognostic Relevance of Circulating Tumor Cells in Primary Breast Cancer.

Janni WJ, Rack B, Terstappen LW, Pierga JY, Taran FA, Fehm T, Hall C, de Groot MR, Bidard FC, Friedl TW, Fasching PA, Brucker SY, Pantel K, Lucci A.

Clin Cancer Res. 2016 May 15;22(10):2583-93. doi: 10.1158/1078-0432.CCR-15-1603. Epub 2016 Jan 5.


Estrogen Receptor and HER2 Status on Disseminated Tumor Cells and Primary Tumor in Patients with Early Breast Cancer.

Jäger BA, Finkenzeller C, Bock C, Majunke L, Jueckstock JK, Andergassen U, Neugebauer JK, Pestka A, Friedl TW, Jeschke U, Janni W, Doisneau-Sixou SF, Rack BK.

Transl Oncol. 2015 Dec;8(6):509-16. doi: 10.1016/j.tranon.2015.11.009.


Heterozygous PALB2 c.1592delT mutation channels DNA double-strand break repair into error-prone pathways in breast cancer patients.

Obermeier K, Sachsenweger J, Friedl TW, Pospiech H, Winqvist R, Wiesmüller L.

Oncogene. 2016 Jul 21;35(29):3796-806. doi: 10.1038/onc.2015.448. Epub 2015 Dec 7.


Predictors for a successful external cephalic version: a single centre experience.

Ebner F, Friedl TW, Leinert E, Schramm A, Reister F, Lato K, Janni W, DeGregorio N.

Arch Gynecol Obstet. 2016 Apr;293(4):749-55. doi: 10.1007/s00404-015-3902-z. Epub 2015 Oct 5.


The influence of obesity on survival in early, high-risk breast cancer: results from the randomized SUCCESS A trial.

Widschwendter P, Friedl TW, Schwentner L, DeGregorio N, Jaeger B, Schramm A, Bekes I, Deniz M, Lato K, Weissenbacher T, Kost B, Andergassen U, Jueckstock J, Neugebauer J, Trapp E, Fasching PA, Beckmann MW, Schneeweiss A, Schrader I, Rack B, Janni W, Scholz C.

Breast Cancer Res. 2015 Sep 18;17:129. doi: 10.1186/s13058-015-0639-3.


Therapeutic intervention based on circulating tumor cell phenotype in metastatic breast cancer: concept of the DETECT study program.

Schramm A, Friedl TW, Schochter F, Scholz C, de Gregorio N, Huober J, Rack B, Trapp E, Alunni-Fabbroni M, Müller V, Schneeweiss A, Pantel K, Meier-Stiegen F, Hartkopf A, Taran FA, Wallwiener D, Janni W, Fehm T.

Arch Gynecol Obstet. 2016 Feb;293(2):271-81. doi: 10.1007/s00404-015-3879-7. Epub 2015 Sep 9.


Obesity as an independent risk factor for decreased survival in node-positive high-risk breast cancer.

Scholz C, Andergassen U, Hepp P, Schindlbeck C, Friedl TW, Harbeck N, Kiechle M, Sommer H, Hauner H, Friese K, Rack B, Janni W.

Breast Cancer Res Treat. 2015 Jun;151(3):569-76. doi: 10.1007/s10549-015-3422-3. Epub 2015 May 13.


Core Competencies in Disaster Management and Humanitarian Assistance: A Systematic Review.

Ripoll Gallardo A, Djalali A, Foletti M, Ragazzoni L, Della Corte F, Lupescu O, Arculeo C, von Arnim G, Friedl T, Ashkenazi M, Fisher P, Hreckovski B, Khorram-Manesh A, Komadina R, Lechner K, Stal M, Patru C, Burkle FM, Ingrassia PL.

Disaster Med Public Health Prep. 2015 Aug;9(4):430-9. doi: 10.1017/dmp.2015.24. Epub 2015 May 5. Review.


Identifying Deficiencies in National and Foreign Medical Team Responses Through Expert Opinion Surveys: Implications for Education and Training--ERRATUM.

Djalali A, Ingrassia PL, Della Corte F, Foletti M, Gallardo AR, Ragazzoni L, Kaptan K, Lupescu O, Arculeo C, von Arnim G, Friedl T, Ashkenazi M, Heselmann D, Hreckovski B, Khorram-Manesh A, Komadina R, Lechner K, Patru C, Burkle FM Jr, Fisher P; Scientific Committee of DITAC Project.

Prehosp Disaster Med. 2015 Apr;30(2):224. doi: 10.1017/S1049023X15004616. No abstract available.


Education in Disaster Management and Emergencies: Defining a New European Course.

Khorram-Manesh A, Ashkenazi M, Djalali A, Ingrassia PL, Friedl T, von Armin G, Lupesco O, Kaptan K, Arculeo C, Hreckovski B, Komadina R, Fisher P, Voigt S, James J, Gursky E.

Disaster Med Public Health Prep. 2015 Jun;9(3):245-55. doi: 10.1017/dmp.2015.9. Epub 2015 Mar 17.


Is open surgery the solution to avoid morcellation of uterine sarcomas? A systematic literature review on the effect of tumor morcellation and surgical techniques.

Ebner F, Friedl TW, Scholz C, Schochter F, Janni W, Vorwerk E, deGregorio N.

Arch Gynecol Obstet. 2015 Sep;292(3):499-506. doi: 10.1007/s00404-015-3664-7. Epub 2015 Feb 26. Review.


Art of disaster preparedness in European union: a survey on the health systems.

Djalali A, Della Corte F, Foletti M, Ragazzoni L, Ripoll Gallardo A, Lupescu O, Arculeo C, von Arnim G, Friedl T, Ashkenazi M, Fischer P, Hreckovski B, Khorram-Manesh A, Komadina R, Lechner K, Patru C, Burkle FM Jr, Ingrassia PL.

PLoS Curr. 2014 Dec 17;6. pii: ecurrents.dis.56cf1c5c1b0deae1595a48e294685d2f. doi: 10.1371/currents.dis.56cf1c5c1b0deae1595a48e294685d2f.


Biodiversity of soil cyanobacteria in the hyper-arid Atacama Desert, Chile.

Patzelt DJ, Hodač L, Friedl T, Pietrasiak N, Johansen JR.

J Phycol. 2014 Aug;50(4):698-710. doi: 10.1111/jpy.12196. Epub 2014 Jun 16.


Biotechnological screening of microalgal and cyanobacterial strains for biogas production and antibacterial and antifungal effects.

Mudimu O, Rybalka N, Bauersachs T, Born J, Friedl T, Schulz R.

Metabolites. 2014 May 15;4(2):373-93. doi: 10.3390/metabo4020373.


Identifying deficiencies in national and foreign medical team responses through expert opinion surveys: implications for education and training.

Djalali A, Ingrassia PL, Corte FD, Foletti M, Gallardo AR, Ragazzoni L, Kaptan K, Lupescu O, Arculeo C, von Arnim G, Friedl T, Ashkenazi M, Heselmann D, Hreckovski B, Khorram-Manesh A, Komadina R, Lechner K, Patru C, Burkle FM, Fisher P; Scientific Committee of DITAC Project.

Prehosp Disaster Med. 2014 Aug;29(4):364-8. doi: 10.1017/S1049023X14000600. Epub 2014 Jun 19. Erratum in: Prehosp Disaster Med. 2015 Apr;30(2):224. Khorrram-Manesh, Amir [corrected to Khorram-Manesh, Amir].


Circulating tumor cells predict survival in early average-to-high risk breast cancer patients.

Rack B, Schindlbeck C, Jückstock J, Andergassen U, Hepp P, Zwingers T, Friedl TW, Lorenz R, Tesch H, Fasching PA, Fehm T, Schneeweiss A, Lichtenegger W, Beckmann MW, Friese K, Pantel K, Janni W; SUCCESS Study Group.

J Natl Cancer Inst. 2014 May 15;106(5). pii: dju066. doi: 10.1093/jnci/dju066. Erratum in: J Natl Cancer Inst. 2014 Sep;106(9):doi/10.1093/jnci/dju273.


Evaluation of two different analytical methods for circulating tumor cell detection in peripheral blood of patients with primary breast cancer.

Jaeger BA, Jueckstock J, Andergassen U, Salmen J, Schochter F, Fink V, Alunni-Fabbroni M, Rezai M, Beck T, Beckmann MW, Friese K, Friedl TW, Janni W, Rack B.

Biomed Res Int. 2014;2014:491459. doi: 10.1155/2014/491459. Epub 2014 Apr 8.


Does Non-Placement of a Drain in Breast Surgery Increase the Rate of Complications and Revisions?

Ebner FK, Friedl TW, Degregorio N, Reich A, Janni W, Rempen A.

Geburtshilfe Frauenheilkd. 2013 Nov;73(11):1128-1134.


Phytoplankton diversity and community composition along the estuarine gradient of a temperate macrotidal ecosystem: combined morphological and molecular approaches.

Bazin P, Jouenne F, Friedl T, Deton-Cabanillas AF, Le Roy B, Véron B.

PLoS One. 2014 Apr 9;9(4):e94110. doi: 10.1371/journal.pone.0094110. eCollection 2014.


Education and training initiatives for crisis management in the European Union: a web-based analysis of available programs.

Ingrassia PL, Foletti M, Djalali A, Scarone P, Ragazzoni L, Corte FD, Kaptan K, Lupescu O, Arculeo C, von Arnim G, Friedl T, Ashkenazi M, Heselmann D, Hreckovski B, Khorram-Manesh A, Komadina R, Lechner K, Patru C, Burkle FM, Fisher P.

Prehosp Disaster Med. 2014 Apr;29(2):115-26. doi: 10.1017/S1049023X14000235. Epub 2014 Mar 18. Review. Erratum in: Prehosp Disaster Med. 2014 Aug;29(4):38. Khorrram-Manesh, Amir [corrected to Khorram-Manesh, Amir].


Interannual variation in land-use intensity enhances grassland multidiversity.

Allan E, Bossdorf O, Dormann CF, Prati D, Gossner MM, Tscharntke T, Blüthgen N, Bellach M, Birkhofer K, Boch S, Böhm S, Börschig C, Chatzinotas A, Christ S, Daniel R, Diekötter T, Fischer C, Friedl T, Glaser K, Hallmann C, Hodac L, Hölzel N, Jung K, Klein AM, Klaus VH, Kleinebecker T, Krauss J, Lange M, Morris EK, Müller J, Nacke H, Pasalic E, Rillig MC, Rothenwöhrer C, Schall P, Scherber C, Schulze W, Socher SA, Steckel J, Steffan-Dewenter I, Türke M, Weiner CN, Werner M, Westphal C, Wolters V, Wubet T, Gockel S, Gorke M, Hemp A, Renner SC, Schöning I, Pfeiffer S, König-Ries B, Buscot F, Linsenmair KE, Schulze ED, Weisser WW, Fischer M.

Proc Natl Acad Sci U S A. 2014 Jan 7;111(1):308-13. doi: 10.1073/pnas.1312213111. Epub 2013 Dec 24.

Supplemental Content

Loading ...
Support Center